Prescription Drug Price Transparency

The Minnesota Legislature passed the Minnesota Prescription Drug Price Transparency Act (Minnesota Statutes 62J.84) to increase transparency into the pricing and cost drivers of prescription drugs. The program is the first in the nation to collect prescription drug pricing data from drug manufacturers, wholesalers, pharmacy benefit managers, and pharmacies and make it available to the public.

The Minnesota Department of Health (MDH) is directed to collect and publish these data. The transparency data, interactive dashboards, research and analysis, reporting resources, and reports to the legislature are all available here online. This work supports the Legislature’s goals specified in the Act:

• Promote transparency in pharmaceutical pricing in Minnesota.
• Enhance the understanding of pharmaceutical spending trends.
• Assist the state and other payers in the management of pharmaceutical costs.

Sign up for email updates to receive news and notifications.

NEW: MDH released the Minnesota Prescription Drug Transparency: 2026 Report to the Minnesota Legislature (PDF). It presents an analysis of information reported by pharmaceutical manufacturers to MDH through the first half of 2025, provides a summary and timeline for the implementation of new work, and assesses the Act’s progress toward statutory goals.